2006-07-01
Reducing cardiovascular disease in patients on peritoneal dialysis - Is it possible?
Publication
Publication
Nephrology, Dialysis, Transplantation , Volume 21 - Issue SUPPL. 2
In summary, patients on PD have a vastly increased risk of cardiovascular disease. Volume overload plays a major role in its pathogenesis. Sodium restriction therefore must be advised in PD patients and supported by a patient education programme. Normovolaemia can be achieved through increased ultrafiltration rate using icodextrin or by increasing residual urine volume with loop-diuretics. Care must be taken to prevent underfilling and the preservation of RRF is crucial. Although it is tempting to assume that the survival benefit of non-dialysis patients on statin treatment will also translate to the PD population, the outcome of ongoing prospective trials is anxiously awaited. Finally, although PD may offer a survival advantage in patients initiating RRT [20,48], PD is currently under-utilized in many parts of the world [50].
| Additional Metadata | |
|---|---|
| doi.org/10.1093/ndt/gfl140, hdl.handle.net/1765/54350 | |
| Nephrology, Dialysis, Transplantation | |
| Organisation | Department of Internal Medicine |
|
Zietse, B.& Marrón, B. (2006). Reducing cardiovascular disease in patients on peritoneal dialysis - Is it possible?. Nephrology, Dialysis, Transplantation, 21(SUPPL. 2).https://doi.org/10.1093/ndt/gfl140 |
|